Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTNFR:Fc plus methotrexate vs placebo plus methotrexate in active rheumatoid arthritis
CTR20150319Phase 3Completed
- Sponsor
- Qilu Pharmaceutical
- Start
- May 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Qilu Pharmaceutical. Started May 2015; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20150319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150319.